References
Eaton JW, Qian M: Molecular bases of cellular iron toxicity. Free Radic Biol Med 2002, 32:833–840.
Nemeth E: Iron regulation and erythropoiesis. Curr Opin Hematol 2008, 15:169–175.
Tang YD, Katz SD: Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options. Circulation 2006, 113:2454–2461.
Auerbach M, Ballard H, Glaspy J: Clinical update: intravenous iron for anaemia. Lancet 2007, 369:1502–1504.
Mancini DM, Katz SD, Lang CC, et al.: Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003, 107:294–299.
Rouault TA, Tong WH: Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat Rev Mol Cell Biol 2005, 6:345–351.
Beard JL: Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 2001, 131:568S–579S; discussion 580S.
Besarab A, Bolton WK, Browne JK, et al.: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 1998, 339:584–590.
Araujo JA, Romano EL, Brito BE, et al.: Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler Thromb Vasc Biol 1995, 15:1172–1180.
Zheng H, Cable R, Spencer B, et al.: Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol 2005, 25:1577–1583.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jelani, Qua., Katz, S.D. Iron in Heart Failure: Friend or Foe?. Curr Heart Fail Rep 7, 49–51 (2010). https://doi.org/10.1007/s11897-010-0012-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11897-010-0012-x